0000000001285484

AUTHOR

Ana Töpf

showing 3 related works from this author

Genome-wide variant calling in reanalysis of exome sequencing data uncovered a pathogenic TUBB3 variant.

2021

Almost half of all individuals affected by intellectual disability (ID) remain undiagnosed. In the Solve-RD project, exome sequencing (ES) datasets from unresolved individuals with (syndromic) ID (n = 1,472 probands) are systematically reanalyzed, starting from raw sequencing files, followed by genome-wide variant calling and new data interpretation. This strategy led to the identification of a disease-causing de novo missense variant in TUBB3 in a girl with severe developmental delay, secondary microcephaly, brain imaging abnormalities, high hypermetropia, strabismus and short stature. Interestingly, the TUBB3 variant could only be identified through reanalysis of ES data using a genome-wi…

ProbandExome sequencingAdolescentDevelopmental Disabilitieslnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]Mutation MissenseComputational biologyBiologyGenomeExonAll institutes and research themes of the Radboud University Medical CenterTubulinIntellectual DisabilitySolve-RDExome SequencingGeneticsCoding regionMissense mutationHumansTUBB3GeneGenetics (clinical)Exome sequencingSequence (medicine)Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7]ERN ITHACABrainMetabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6]General MedicineGenome-wide variant callingStrabismusFaceMicrocephalyFemaleEuropean journal of medical genetics
researchProduct

Molecular characterization of congenital myasthenic syndromes in Spain.

2017

Congenital myasthenic syndromes (CMS) are a heterogeneous group of genetic disorders, all of which impair neuromuscular transmission. Epidemiological data and frequencies of gene mutations are scarce in the literature. Here we describe the molecular genetic and clinical findings of sixty-four genetically confirmed CMS patients from Spain. Thirty-six mutations in the CHRNE, RAPSN, COLQ, GFPT1, DOK7, CHRNG, GMPPB, CHAT, CHRNA1, and CHRNB1 genes were identified in our patients, with five of them not reported so far.. These data provide an overview on the relative frequencies of the different CMS subtypes in a large Spanish population. CHRNE mutations are the most common cause of CMS in Spain, …

AdultMale0301 basic medicineSlow-channel syndromeAdolescentNeuromuscular transmissionGMPPBGene mutationCOLQCongenital myasthenic syndromeYoung Adult03 medical and health sciences0302 clinical medicineDOK7COLQmedicineHumansCHRNECHRNEGeneGenetics (clinical)health care economics and organizationsMyasthenic Syndromes CongenitalGeneticsbiologyRAPSNMiddle AgedCongenital myasthenic syndromemedicine.diseasePhenotype3. Good healthGenetic mutationsRAPSN030104 developmental biologyGFPT1NeurologySpainPediatrics Perinatology and Child Healthbiology.proteinFemaleNeurology (clinical)030217 neurology & neurosurgery
researchProduct

SNV-InDel working group: Results and lessons learned from the analysis of 22,035 exomes and genomes from 6 European reference networks

2023

Diagnostic Odyssey[SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics
researchProduct